Resonate Blends (Resonate Blends) Risk Assessment

View and export this data going back to 1993. Start your Free Trial

What is Resonate Blends Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Resonate Blends is: No Data: Cannot be evaluated.

Competitive Comparison of Resonate Blends's Risk Assessment

For the Drug Manufacturers - Specialty & Generic subindustry, Resonate Blends's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Resonate Blends's Risk Assessment Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Resonate Blends's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Resonate Blends's Risk Assessment falls into.

Resonate Blends (OTCPK:KOAN) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Resonate Blends Risk Assessment Related Terms

Thank you for viewing the detailed overview of Resonate Blends's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Resonate Blends (Resonate Blends) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Resonate Blends Inc (OTCPK:KOAN) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

26565 Agoura Road, Suite 200, Calabasas, CA, USA, 91302

Website

https://www.resonateblends.com

Resonate Blends Inc is a cannabis/hemp-based holding company. It is focused on a vertically integrated and valued-added Wellness and Lifestyle brand.

Executives

Richard Hoge	10 percent owner	C/O JIM KEARNEY, 760 SW 9TH AVE. STE 3000, PORTLAND OR 97205
Pamela Kerwin	officer: Chief Operating Officer	26565 AGOURA ROAD, SUITE 200, CALABASAS CA 91302
Geoffrey Selzer	director, officer: Chief Executive Officer	26565 AGOURA ROAD, SUITE 200, CALABASAS CA 91302
David Thomas Thielen	10 percent owner, officer: COO	1940 CONTRA COSTA BLVD., PLEASANT HILL CA 94523
Nick Allen Miniello	10 percent owner, officer: VP of Sales	1940 CONTRA COSTA BLVD., PLEASANT HILL CA 94523
Wais Asefi	director, 10 percent owner, officer: CEO	1940 CONTRA COSTA BLVD., PLEASANT HILL CA 94523
Sterling John M Iii	director
Gregory Oliver Sargent	10 percent owner	1609 FAIRFIELD BEACH ROAD, FAIRFIELD CT 06824
Steven Richard Deerwester	officer: Vice President	3125 DARTMOUTH PLACE, CUMMING GA 30041
David G Kane	other: Controller	50 JOE LEE DRIVE, SHARPSBURG GA 30277
I Sigmund Mosley	director	945 E PACES FERRY RD, SUITE 2450, ATLANTA GA 30326
Vincent J Dooley	director	2859 PACES FERRY ROAD, SUITE 1000, ATLANTA GA 30339
Spencer John N Jr	director	2859 PACES FERRY RD, STE 1000, ATLANTA GA 30339
Marsha K Calfee	officer: VP of Product Development
Jeffrey Longoria	officer: VP of Sales